Somamers Somalogic Using DeCode Deal to Drive Development of Clinical Proteomics Pipeline Premium The firm is using collaborations to access the large, diverse cohorts it needs to support its goal of commercializing its SomaScan system as a clinical platform. Somalogic, DeCode Collaborating on Proteomic Project The companies will use Somalogic's SomaScan proteomic platform to measure levels of as many as 5,000 proteins in up to 40,000 of DeCode's patient samples. European Consortium Aims to Deliver New Tests, Therapies for Cardiovascular Diseases Premium Backed by €19 million in EU funding, the initiative, called [email protected], will create a research platform that could change the way cardiovascular diseases are diagnosed and treated. SomaLogic Inks Deal With BMS for Use of SOMAscan Platform Under the agreement, BMS has access to the 1,310 reagents in the public version of SomaLogic's SOMAscan assay along with a number of custom-developed reagents. Somalogic Publishes Validation Study on 13-Protein Dx for Detection of Mesothelioma Premium Proteomics diagnostics firm Somalogic reported data this week supporting the utility of its blood-based 13-protein panel for the detection of malignant mesothelioma. Apr 20, 2012 Somalogic Publishes First Data on Use of Somascan in Tissue Samples, Considers Offering Reagents for IHC Premium Apr 13, 2012 Somalogic Teams with HUNT for 2,000-Patient Validation Study of Cardiovascular Biomarkers Premium Oct 21, 2011 With Novartis Deal, Release of New Discovery Panel, Somalogic Targets Proteomics Services Market Premium Jul 28, 2011 SomaLogic to Provide Reagents for New England Biolabs' PCR Products Premium Jul 27, 2011 SomaLogic, New England Biolabs Partner on PCR Products May 7, 2011 Some Proteomics Firms Exploring Next-Generation Sequencing for Biomarker Research Premium Apr 22, 2011 NCI's Early Detection Research Network Running Trials to Compare Biomarker-Based Cancer Diagnostics Premium Apr 8, 2011 NYU, Somalogic Present Data on Protein Biomarker Test for Mesothelioma Premium Dec 10, 2010 SomaLogic Launching Validation and Prospective Trials for Protein Biomarker Lung Cancer Diagnostic Premium Oct 15, 2010 Somalogic Launches Validation Studies of Protein Biomarkers for Pancreatic Cancer and Mesothelioma Premium Sep 10, 2010 Somalogic Partners with NEC in Effort to More Broadly Leverage Aptamer-Based Technology Premium Breaking News Lunaphore Technologies, University of Bern Partner on Colorectal Cancer Study People in the News: New Appointments at Biocept, Novacyt, Centogene, Illumina, More In Brief This Week: Sophia Genetics, Twist Bioscience, Dante Labs, MGI, Codex DNA, More New Products Posted to GenomeWeb: SpeeDx, Bio-Techne, NuProbe, More DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests The Scan Interfering With Invasive Mussels The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels. Participation Analysis A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports. Right Whales' Decline A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC. Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.